Nature Biotechnology Features Origent’s ALS Technologies
In the latest issue of “Nature Biotechnology”, scientists evaluated an algorithm developed by Dr. Liuxia Wang and Guang “Eric” Li for predicting the disease progression of patients living with amyotrophic lateral sclerosis (ALS), also known as motor neuron...
Origent Takes the ALS Ice Bucket Challenge
Origent joined with our affiliate company Sentrana to participate in the ALS Ice Bucket Challenge. When making your donation to this important cause, please consider the following organizations:
Origent and Sentrana – Joining the Battle to Cure ALS
Origent CEO Mike Keymer and Sentrana CEO Syeed Mansur discuss how a precision sales and marketing company came to join in the battle to find a cure for amyotrophic lateral sclerosis.